Three decades of clinical trials have changed the face of HIV/AIDS.
Scientists from around the world will gather at UAB in December to focus on HIV research and women, particularly collaborative research on women living with HIV and those at risk.
Antibody VRC01 proves safe for individuals infected with HIV-1 but only modestly controls the virus in participants who stop receiving antiretroviral therapy.
A UAB expert recommends international travelers consult with a physician four to six weeks prior to travel and learn medical risks and how to prevent illness while abroad.
James H. Willig, M.D., MSPH, associate professor in the Division of Infectious Diseases, has been named the assistant dean for Clinical Education, a new position that will strengthen collaborative and coordinated clinical training for medical students.
High mosquito and human population densities, combined with mosquito breeding conditions, are the central cause for Zika virus.
Eleven outstanding faculty members were named recipients of the 2016 Dean’s Excellence Awards, an honor recognizing exceptional contributions made by School of Medicine faculty in service, teaching, research, diversity enhancement and mentorship.
An international clinical trial for a new HIV antibody, VRC01 begins in late spring at UAB as part of the Antibody Mediated Prevention study.
UAB assistant professor leads the way in providing therapy for HIV patients with chronic pain.
Researcher focused on HIV and STD prevention in women will lead UAB School of Medicine Division of Infectious Diseases.